Alnylam

Articles

Fast Co February 20, 2019 Alnylam Named a Fast Company World's Most Innovative Company for 2019 Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019. Read More ›
Bloomberg Top 50 December 11, 2018 John Maraganore Named to Bloomberg 50 List for 2018 Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018. Read More ›
TPTW 2018 November 16, 2018 Alnylam Named a Boston Globe Top Place to Work for the 4th Year in a Row Alnylam has been named to the Boston Globe's list of Top Places to Work for 2018 marking our fourth year in a row on the list.  We are ranked #18 out of the... Read More ›
Nature Biotech September 10, 2018 A Triumph of Perseverance Over Interference [Nature Biotechnology] The following Editorial appeared in Nature Biotechnology (36,775 2018) on September 6, 2018... "A triumph of perseverance over interference"... Read More ›
RNAi August 11, 2018 New Kind of Drug, Silencing Genes, Gets FDA Approval [Wall Street Journal] The following article appeared in The Wall Street Journal on August 10, 2018... "New Kind of Drug, Silencing Genes, Gets FDA Approval"... Read More ›
Barry PharmaVOICE 100 2018 NH August 3, 2018 Barry Greene Named to PharmaVoice 100 "For Being an RNAi Champion" Alnylam President Barry Greene has been named to the PharmaVoice 100 for 2018.  Barry was selected "for being an RNAi champion." Read More ›
Muriel banner June 19, 2018 Guest Post: Finding Hope in a Potential New Class of Medicines Amyloidosis first entered my husband’s life and my life in the mid-1990s, when we began to care for my uncle who had amyloidosis, a time I call the “dark ages. Read More ›
Two people standing together in a historic city square with stone architecture in the background June 19, 2018 Guest Post: The Heroes Among Us For many of us, it’s unimaginable to think of a daily life filled with intractable pain. It’s also hard to imagine caring for someone in pain of that... Read More ›
Kevin F at Research Offsite 2018 April 30, 2018 Hunting for Targets: Bringing RNAi to Humans Evolution is a powerful force, and Mother Nature is often a great source of inspiration for drug hunters like me. If you look at the history of successful... Read More ›
RNAi April 30, 2018 Building to Scale: Raising RNAi Therapeutics From Infancy When I joined Alnylam in 2004, one of our early challenges was figuring out how to manufacture and deliver RNAi therapeutics for our clinical trials. The... Read More ›
Subscribe to Articles